Compounds > 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Breast Neoplasms

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Breast Neoplasms in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (6.25)18.2507
2000's9 (28.13)29.6817
2010's17 (53.13)24.3611
2020's4 (12.50)2.80

Authors

AuthorsStudies
Cai, L; Chen, Y; Wang, W; Xu, T; Yang, C1
Aksoy, T; Alçın, G; Arslan, E; Baykara Ulusan, M; Çermik, TF; Ergül, N1
Colcher, DM; Fong, Y; Frankel, P; Hernandez, MC; Kim, J; Mortimer, JE; Park, J; Poku, E; Shively, J; Wong, J; Woo, Y; Yamauchi, D; Yazaki, P1
Bruchertseifer, F; Denkova, AG; Heskamp, S; Kip, A; Kruijff, RM; Molkenboer-Kuenen, J; Morgenstern, A; Raavé, R1
Chang, CH; Chen, LC; Chen, MW; Lee, SY; Liang, CH; Liu, IJ; Lo, SN; Lo, WL; Lu, RM; Wu, HC1
Guo, H; Hathaway, H; Miao, Y; Prossnitz, ER; Royce, ME1
Chen, CP; Gray, BD; Mattis, JA; Mehta, N; Mitchell, EP; Pak, KY; Paudyal, B; Thakur, ML; Wampole, ME; Wickstrom, E; Zhang, K1
Akhurst, TJ; Beylergil, V; Carrasquillo, JA; Hudis, CA; Larson, SM; Lu, Y; Lyashchenko, SK; Modi, S; Morris, PG; O'Donoghue, J; Smith-Jones, PM; Solit, D1
Burnet, JC; de Araújo, EB; Finucane, C; Foster, JM; Hudson, CD; Mather, SJ; Mengatti, J; Pasqualoto, KFM; Pujatti, PB; Sosabowski, JK1
Berthelsen, AK; Brandt-Larsen, M; Brasso, K; Christensen, C; Holm, S; Højgaard, L; Kjaer, A; Klausen, TL; Kroman, N; Loft, A; Madsen, J; Nielsen, CH; Pappot, H; Persson, M; Ploug, M; Skovgaard, D; Thurison, T1
Alwarda, R; Cai, Z; Jeong, JJ; Lu, Y; Pignol, JP; Reilly, RM; Tong, L; Winnik, MA; Yook, S1
Bal, A; Bhusari, P; Dhawan, DK; Mittal, BR; Parmar, M; Shukla, J; Singh, G; Vatsa, R1
Babaei, MH; Daha, FJ; Rajabi, H; Rasaneh, S; Salouti, M1
Barnhart, TE; Cai, W; Engle, JW; Hong, H; Leigh, BR; Nickles, RJ; Yang, Y; Zhang, Y1
Capala, J; Choyke, P; Griffiths, GL; Kramer-Marek, G; Seidel, J; Shenoy, N1
Ait-Mohand, S; Bénard, F; Dumulon-Perreault, V; Ferreira, CL; Fournier, P; Guérin, B; Jurek, P; Kiefer, GE1
Babaei, MH; Rajabi, H; Rasaee, Mj; Salouti, M1
Al-Nahhas, A1
Allen, C; Fonge, H; Huang, H; Reilly, RM; Scollard, D1
Cheng, Z; Gambhir, SS; Liu, H; Liu, Z; Miao, Z; Ren, G; Syud, FA; Webster, JM; Zhang, R1
Abbas, N; Brevik, EM; Dahle, J; Heyerdahl, H; Mollatt, C1
Chordia, MD; Chung, LW; Pan, D; Wang, JP; Xiao, L; Xie, X; Yue, W; Zhang, Y1
Areces, L; Bussolati, G; Cassoni, P; Chini, B; Chinol, M; Manning, M; Marrocco, T; Paganelli, G; Papi, S; Reversi, A1
DeNardo, GL; DeNardo, SJ; Hartmann-Siantar, C; Lam, KS; Lamborn, KR; Miers, LA; Peterson, JJ1
DeNardo, GL; DeNardo, SJ1
Chew, HK; DeNardo, GL; Denardo, SJ; Goldstein, DS; Kukis, DL; Lamborn, KR; Lara, PN; Meares, CF; Natarajan, A; O'Donnell, RT; Richman, CM; Shen, S; Tuscano, JM; Wun, T; Yuan, A1
DeNardo, G; DeNardo, S; Lamborn, K; Miers, L; Natarajan, A; Richman, C; Yuan, A1
Cai, W; Cao, Q; Chen, K; Chen, X; Tice, DA; Wu, Y1
Deutscher, SL; Kumar, SR1
DeNardo, SJ; Kukis, DL; Li, M; Meares, CF; Miers, L; Salako, Q; Zhong, GR1
Bussolati, G; Cassoni, P; Chini, B; Chinol, M; Nacca, A; Paganelli, G1
Courtenay-Luck, NS; Epenetos, AA; Gooden, CS; Kosmas, C; McCall, MJ; Meares, CF; Snook, D1

Trials

4 trial(s) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Breast Neoplasms

ArticleYear
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
    Theranostics, 2015, Volume: 5, Issue:12

    Topics: Breast Neoplasms; Copper Radioisotopes; Drug-Related Side Effects and Adverse Reactions; Female; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Molecular Imaging; Oligopeptides; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Protein Binding; Receptors, Urokinase Plasminogen Activator; Urinary Bladder Neoplasms

2015
Development of Lu-177-trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients.
    International journal of cancer, 2017, 02-15, Volume: 140, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Feasibility Studies; Female; Genes, erbB-2; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Lutetium; Mastectomy; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasm Proteins; Pilot Projects; Radioimmunotherapy; Radioisotopes; Receptor, ErbB-2; Single Photon Emission Computed Tomography Computed Tomography; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tamoxifen; Tissue Distribution; Trastuzumab

2017
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-15, Volume: 11, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Cathepsins; Combined Modality Therapy; Cyclosporine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Mice; Middle Aged; Neutropenia; Paclitaxel; Prostatic Neoplasms; Radioimmunotherapy; Soft Tissue Neoplasms; Treatment Outcome; Yttrium Radioisotopes

2005
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Cancer research, 1992, Feb-15, Volume: 52, Issue:4

    Topics: Aged; Antibodies; Antibodies, Monoclonal; Antibody Formation; Breast; Breast Neoplasms; Chelating Agents; Drug Evaluation; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radioimmunotherapy; Radionuclide Imaging; Stomach Neoplasms; Testicular Neoplasms; Yttrium Radioisotopes

1992

Other Studies

28 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Breast Neoplasms

ArticleYear
68Ga-DOTA-FAPI-04 Uptake of Accessory Breast in a Patient With Breast Cancer.
    Clinical nuclear medicine, 2022, Jun-01, Volume: 47, Issue:6

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Positron Emission Tomography Computed Tomography; Quinolines

2022
68 Ga-DOTA-FAPI-04 Imaging of Bilateral Phyllodes Tumor.
    Clinical nuclear medicine, 2023, Oct-01, Volume: 48, Issue:10

    Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Phyllodes Tumor; Positron Emission Tomography Computed Tomography

2023
Pilot study of HER2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
    Nuclear medicine communications, 2023, Dec-01, Volume: 44, Issue:12

    Topics: Breast Neoplasms; Female; Humans; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab

2023
The in vivo fate of
    Scientific reports, 2019, 08-12, Volume: 9, Issue:1

    Topics: Actinium; Alpha Particles; Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Drug Carriers; Female; Heterocyclic Compounds, 1-Ring; Humans; Injections, Intralesional; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Radiopharmaceuticals; Survival Analysis; Tumor Burden

2019
Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2020, Volume: 161

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Mice; Mice, Inbred NOD; Mice, SCID; Multimodal Imaging; Oligopeptides; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays

2020
Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides.
    Bioorganic & medicinal chemistry letters, 2013, Oct-15, Volume: 23, Issue:20

    Topics: Aminocaproates; Animals; Breast Neoplasms; Caprylates; Cell Line, Tumor; Fatty Acids; Female; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Heterocyclic Compounds, 1-Ring; Humans; Hydrocarbons; Mice; Mice, Nude; Peptides; Protein Binding; Receptors, LHRH; Tissue Distribution; Transplantation, Heterologous

2013
Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:8

    Topics: Animals; Breast Neoplasms; Cell Transformation, Neoplastic; Copper Radioisotopes; Doxorubicin; Female; Heterocyclic Compounds, 1-Ring; Humans; Insulin-Like Growth Factor I; Mice; Peptide Nucleic Acids; Positron-Emission Tomography; Receptor, ErbB-2; RNA, Messenger; Tomography, X-Ray Computed; Treatment Outcome

2013
Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.
    Nuclear medicine communications, 2013, Volume: 34, Issue:12

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Feasibility Studies; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Radiometry; Safety; Tomography, X-Ray Computed; Trastuzumab

2013
Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2015, Volume: 96

    Topics: Animals; Bombesin; Breast Neoplasms; Cell Line, Tumor; Drug Stability; Female; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; In Vitro Techniques; Indium Radioisotopes; Male; Mice, SCID; Neoplasm Transplantation; Pentetic Acid; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution

2015
Stability and Biodistribution of Thiol-Functionalized and (177)Lu-Labeled Metal Chelating Polymers Bound to Gold Nanoparticles.
    Biomacromolecules, 2016, Apr-11, Volume: 17, Issue:4

    Topics: Animals; Beta Particles; Breast Neoplasms; Female; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Metal Nanoparticles; Mice; Mice, Nude; Nanomedicine; Polymers; Radioisotopes; Radiopharmaceuticals; Sulfhydryl Compounds

2016
Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Buffers; Cell Line, Tumor; Cell Survival; Drug Stability; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Quality Control; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Staining and Labeling; Trastuzumab

2009
Positron emission tomography imaging of CD105 expression during tumor angiogenesis.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Breast Neoplasms; Cell Line, Tumor; Copper Radioisotopes; Endoglin; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Mice; Neovascularization, Pathologic; Positron-Emission Tomography; Receptors, Cell Surface

2011
68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:11

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Mice; Multimodal Imaging; Positron-Emission Tomography; Receptor, ErbB-2; Recombinant Fusion Proteins; Tomography, X-Ray Computed

2011
Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
    Bioconjugate chemistry, 2011, Aug-17, Volume: 22, Issue:8

    Topics: Binding, Competitive; Bombesin; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Copper Radioisotopes; Drug Stability; Female; Heterocyclic Compounds, 1-Ring; Humans; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Bombesin; Structure-Activity Relationship

2011
Preparation and biological evaluation of (177)Lu conjugated PR81 for radioimmunotherapy of breast cancer.
    Nuclear medicine and biology, 2011, Volume: 38, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Female; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Mice; Mice, Inbred BALB C; Quality Control; Radioimmunodetection; Radioimmunotherapy; Radioisotopes

2011
Detection of unsuspected bone metastases by ⁶⁸Ga-DOTA: nuclear medicine at the forefront again.
    Nuclear medicine communications, 2011, Volume: 32, Issue:10

    Topics: Bone Neoplasms; Breast Neoplasms; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Neoplasm Micrometastasis; Nuclear Medicine

2011
Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Feb-10, Volume: 157, Issue:3

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Chemistry, Pharmaceutical; Epidermal Growth Factor; Heterocyclic Compounds, 1-Ring; Humans; Mice; Mice, Nude; Micelles; Neoplasm Transplantation; Pentetic Acid; Polymers; Tissue Distribution

2012
In vivo targeting of HER2-positive tumor using 2-helix affibody molecules.
    Amino acids, 2012, Volume: 43, Issue:1

    Topics: Animals; Binding Sites; Breast Neoplasms; Copper Radioisotopes; Female; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Mice; Mice, Nude; Molecular Mimicry; Neoplasm Transplantation; Ovarian Neoplasms; Positron-Emission Tomography; Protein Binding; Proteins; Receptor, ErbB-2; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous

2012
Fractionated therapy of HER2-expressing breast and ovarian cancer xenografts in mice with targeted alpha emitting 227Th-DOTA-p-benzyl-trastuzumab.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Animals; Antibodies, Monoclonal, Humanized; Autoradiography; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Heterocyclic Compounds, 1-Ring; Humans; Leukocyte Count; Mice; Mice, Nude; Organometallic Compounds; Ovarian Neoplasms; Receptor, ErbB-2; Survival Analysis; Time Factors; Trastuzumab; Tumor Burden; Weight Loss; Xenograft Model Antitumor Assays

2012
Heptamethine cyanine based (64)Cu-PET probe PC-1001 for cancer imaging: synthesis and in vivo evaluation.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:3

    Topics: Animals; Biological Transport; Breast Neoplasms; Carbocyanines; Cell Transformation, Neoplastic; Chemistry Techniques, Synthetic; Copper Radioisotopes; Female; Heterocyclic Compounds, 1-Ring; Humans; MCF-7 Cells; Mice; Positron-Emission Tomography; Spectrometry, Fluorescence; Tumor Burden

2013
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.
    British journal of cancer, 2003, Sep-01, Volume: 89, Issue:5

    Topics: Animals; Breast Neoplasms; Carcinoma; Chelating Agents; COS Cells; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Neoplasms; Oxytocin; Protein Binding; Radioactive Tracers; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Oxytocin; Sensitivity and Specificity; Stomach Neoplasms; Tissue Distribution; Transfection; Tumor Cells, Cultured; Vasotocin

2003
Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 2

    Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cathepsins; Chelating Agents; Chromatography, High Pressure Liquid; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Indium Radioisotopes; Linear Models; Liver; Lymphoma; Mice; Mice, Nude; Models, Chemical; Neoplasm Transplantation; Peptides; Radioimmunotherapy; Time Factors

2003
Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patients.
    Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:1

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cathepsins; Chelating Agents; Female; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Indium Radioisotopes; Liver; Male; Mice; Mice, Nude; Peptides; Prostatic Neoplasms

2004
Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 2

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Female; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin G; Indium Radioisotopes; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Paclitaxel; Prostatic Neoplasms; Radioimmunotherapy; Time Factors

2005
In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
    Cancer research, 2006, Oct-01, Volume: 66, Issue:19

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Copper Radioisotopes; Female; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Integrin alphaVbeta3; Male; Mice; Mice, Nude; Neoplasm Proteins; Organometallic Compounds; Positron-Emission Tomography; Prostatic Neoplasms; Radiography; Radioimmunodetection; Radiometry; Tissue Distribution

2006
111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:5

    Topics: Amino Acid Sequence; Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Female; Galectin 3; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Mice; Molecular Sequence Data; Neoplasm Transplantation; Peptides; Staining and Labeling; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2008
Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.
    Cancer research, 1995, Dec-01, Volume: 55, Issue:23 Suppl

    Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Antibodies, Neoplasm; Breast Neoplasms; Drug Delivery Systems; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Radioimmunotherapy; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes

1995
111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors.
    Cancer research, 2001, Jun-01, Volume: 61, Issue:11

    Topics: Animals; Breast Neoplasms; COS Cells; Female; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Indium Radioisotopes; Isotope Labeling; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radiopharmaceuticals; Receptors, Oxytocin; Tissue Distribution; Vasotocin

2001